Bypassing immune evasion in colorectal cancer by integrin inhibition-mediated downregulation of PD-L1

被引：0
|
作者：
MacDonald, William J.
Verschleiser, Brooke
Carlsen, Lindsey
Huntington, Kelsey E.
El-Deiry, Wafik S.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4438
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4438
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Echinacoside inhibits tumor immune evasion by downregulating inducible PD-L1 and reshaping tumor immune landscape in breast and colorectal cancer
    Wang, Xiaoyu
    Tan, Binxin
    Liu, Jiazhou
    Wang, Jing
    Chen, Mingjing
    Yang, Qian
    Zhang, Xiang
    Li, Fan
    Wei, Yuxian
    Wu, Ke
    Ren, Guosheng
    Li, Hongzhong
    PHYTOMEDICINE, 2024, 135
  • [22] Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer via FOSB-Mediated Downregulation of MicroRNA-22 through BATF3/PD-L1 Pathway
    Tian, Jiale
    Wang, Weiwei
    Zhu, Jichao
    Zhuang, Yun
    Qi, Chunrun
    Cai, Zhengxin
    Yan, Wenhui
    Lu, Wenying
    Shang, Anquan
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [23] TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer
    Dai, Xiaofeng
    Wu, Zhipeng
    Ruan, Ruiwen
    Chen, Jingyi
    Huang, Chunye
    Lei, Wan
    Yao, Yangyang
    Li, Li
    Tang, Xiaomei
    Xiong, Jianping
    Feng, Miao
    Deng, Jun
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [24] TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer
    Xiaofeng Dai
    Zhipeng Wu
    Ruiwen Ruan
    Jingyi Chen
    Chunye Huang
    Wan Lei
    Yangyang Yao
    Li Li
    Xiaomei Tang
    Jianping Xiong
    Miao Feng
    Jun Deng
    Cell Communication and Signaling, 22
  • [25] Metformin suppresses tumor immune evasion through downregulation of PD-L1 expression in cancer cells and PD-1 expression in NK cells and T cells
    Park, Su Hwan
    Lee, Jong-Ho
    CANCER RESEARCH, 2023, 83 (07)
  • [26] Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
    Wang, Yiting
    Shi, Hubing
    Meng, Huan
    Xu, Jie
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [27] Targeting the PD-1/PD-L1 immune evasion axis with DNA aptamers
    Prodeus, Aaron
    Gariepy, Jean
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [28] PKCα inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability
    Yu, Jiaojiao
    Xiang, Yujin
    Gao, Yuzhen
    Hua, Fang
    Zhang, Xiaowei
    Li, Pingping
    Cui, Bing
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 771 - 772
  • [29] PKCa inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability
    Yu, Jiaojiao
    Xiang, Yujin
    Gao, Yuzhen
    Chang, Shan
    Kong, Ren
    Lv, Xiaoxi
    Yu, Jinmei
    Jin, Yunjie
    Li, Chenxi
    Ma, Yiran
    Wang, Zhenhe
    Zhou, Jichao
    Yuan, Hongyu
    Shang, Shuang
    Hua, Fang
    Zhang, Xiaowei
    Cui, Bing
    Li, Pingping
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (10) : 4378 - 4395
  • [30] CTC immune escape mediated by PD-L1
    Wang, Xuefei
    Sun, Qiang
    Liu, Qiaofei
    Wang, Changjun
    Yao, Ru
    Wang, Yimin
    MEDICAL HYPOTHESES, 2016, 93 : 138 - 139
12345